Real-time enrollment status for this chronic lymphocytic leukemia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:29 AM UTC
| NCT Number | NCT05947851 |
| Recruiting Status | Recruiting |
| Condition | Chronic Lymphocytic Leukemia |
| Phase | PHASE3 |
| Target Enrollment | 735 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | May 18, 2026 (May 18, 2026) |
As of July 17, 2026: Clinical trial NCT05947851 is currently recruiting participants. This phase3 study for chronic lymphocytic leukemia is actively seeking new participants at 6 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05947851 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05947851 was last updated May 18, 2026 (May 18, 2026). HelloStudys verifies this status automatically.